Search

Coloplast A-S (Class B)

Fermé

541.6 1.65

Résumé

Variation du prix de l'action

24h

Actuel

Min

530.4

Max

542

Chiffres clés

By Trading Economics

Revenu

70M

875M

Ventes

2M

7B

P/E

Moyenne du Secteur

33.065

90.422

BPA

3.88

Rendement du dividende

4.26

Marge bénéficiaire

12.572

Employés

16,744

EBITDA

2B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.26%

2.13%

Prochains Résultats

6 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-2.3B

120B

Ouverture précédente

539.95

Clôture précédente

541.6

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

28 janv. 2026, 23:51 UTC

Résultats

Correction to Samsung Fourth-Quarter Net Profit Article

28 janv. 2026, 23:49 UTC

Actions en Tendance

Stocks to Watch: Meta, IBM, Las Vegas Sands, Whirlpool

28 janv. 2026, 23:19 UTC

Résultats

Samsung's Fourth-Quarter Net Profit Beats Consensus

28 janv. 2026, 22:43 UTC

Résultats

Waste Management Logs Higher 4Q Profit as Revenue Rises

29 janv. 2026, 00:00 UTC

Acquisitions, Fusions, Rachats

Diller's Overture Came Before Warner Unveiled Split Plans, Source Says -- WSJ

29 janv. 2026, 00:00 UTC

Acquisitions, Fusions, Rachats

Warner Says CNN Wasn't and Isn't for Sale -- WSJ

29 janv. 2026, 00:00 UTC

Acquisitions, Fusions, Rachats

Barry Diller Told Warner Bros. Discovery He Is Interested in Buying CNN -- WSJ

29 janv. 2026, 00:00 UTC

Acquisitions, Fusions, Rachats

Barry Diller Approached Warner Bros. Discovery Last Year About Buying CNN, Sources Say -- WSJ

28 janv. 2026, 23:49 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

28 janv. 2026, 23:30 UTC

Market Talk

Tesla to Use Car Factory for Robot Aims -- Market Talk

28 janv. 2026, 23:28 UTC

Résultats

Microsoft's Earnings Surge, Elevated by Cloud Business -- 3rd Update

28 janv. 2026, 23:26 UTC

Résultats

Meta Reports Record Sales, Massive Spending Hike on AI Buildout -- 2nd Update

28 janv. 2026, 23:21 UTC

Résultats

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 janv. 2026, 23:18 UTC

Résultats
Acquisitions, Fusions, Rachats

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 janv. 2026, 22:58 UTC

Résultats

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 janv. 2026, 22:48 UTC

Market Talk

Woodside Energy Has Form With Conservative Production Guidance -- Market Talk

28 janv. 2026, 22:45 UTC

Résultats

Samsung Electronics 2025 Net KRW45.207T Vs. Net KRW34.451T >005930.SE

28 janv. 2026, 22:44 UTC

Résultats

Samsung Electronics 2025 Oper Pft KRW43.601T Vs. Pft KRW32.726T >005930.SE

28 janv. 2026, 22:43 UTC

Résultats

Samsung Electronics 2025 Rev KRW333.606T Vs. KRW300.871T >005930.SE

28 janv. 2026, 22:41 UTC

Résultats
Actions en Tendance

Earnings in Focus Wednesday: Microsoft, Tesla, Meta, Starbucks -- WSJ

28 janv. 2026, 22:41 UTC

Market Talk

Rising AUD Typically Sees Australian Stocks Outperform -- Market Talk

28 janv. 2026, 22:41 UTC

Résultats

Meta Stock Rises on Strong Earnings. Expenses Are Mounting. -- Barrons.com

28 janv. 2026, 22:40 UTC

Résultats

Samsung Electronics 4Q Net Profit Beat FactSet-Compiled Consensus

28 janv. 2026, 22:39 UTC

Résultats

Samsung Electronics 4Q Net KRW19.642T Vs. Net KRW7.754T >005930.SE

28 janv. 2026, 22:38 UTC

Résultats

Samsung Electronics 4Q Oper Pft KRW20.074T Vs. Pft KRW6.493T >005930.SE

28 janv. 2026, 22:37 UTC

Résultats

Samsung Electronics 4Q Rev KRW93.837T Vs. KRW75.788T >005930.SE

28 janv. 2026, 22:35 UTC

Résultats

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 janv. 2026, 22:26 UTC

Market Talk
Résultats

Meta's Rising CapEx is Fueled by High Pay for AI Workers -- Market Talk

28 janv. 2026, 22:20 UTC

Market Talk

Global Equities Roundup: Market Talk

28 janv. 2026, 22:20 UTC

Market Talk

Woodside Energy's Oil Assets Blamed for Guidance Miss -- Market Talk

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat